Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment

Lorena Bonilla-Vidal,1,2 Marta Świtalska,3 Marta Espina,1,2 Joanna Wietrzyk,3 Maria Luisa García,1,2 Eliana B Souto,4,5 Anna Gliszczyńska,6,* Elena Sánchez López1,2,7,* 1Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, University of Barc...

Full description

Bibliographic Details
Main Authors: Bonilla-Vidal L, Świtalska M, Espina M, Wietrzyk J, García ML, Souto EB, Gliszczyńska A, Sánchez López E
Format: Article
Language:English
Published: Dove Medical Press 2023-11-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/dually-active-apigenin-loaded-nanostructured-lipid-carriers-for-cancer-peer-reviewed-fulltext-article-IJN
_version_ 1797486301447979008
author Bonilla-Vidal L
Świtalska M
Espina M
Wietrzyk J
García ML
Souto EB
Gliszczyńska A
Sánchez López E
author_facet Bonilla-Vidal L
Świtalska M
Espina M
Wietrzyk J
García ML
Souto EB
Gliszczyńska A
Sánchez López E
author_sort Bonilla-Vidal L
collection DOAJ
description Lorena Bonilla-Vidal,1,2 Marta Świtalska,3 Marta Espina,1,2 Joanna Wietrzyk,3 Maria Luisa García,1,2 Eliana B Souto,4,5 Anna Gliszczyńska,6,* Elena Sánchez López1,2,7,* 1Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, University of Barcelona, Barcelona, Spain; 2Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain; 3Department of Experimental Oncology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland; 4Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal; 5Associate Laboratory i4HB—Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; 6Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Wrocław, Poland; 7Unit of Synthesis and Biomedical Applications of Peptides, IQAC-CSIC, Barcelona, Spain*These authors contributed equally to this workCorrespondence: Elena Sánchez López; Anna Gliszczyńska, Email esanchezlopez@ub.edu; anna.gliszczynska@upwr.edu.plPurpose: Cancer is one of the major causes of death worldwide affecting more than 19 million people. Traditional cancer therapies have many adverse effects and often result in unsatisfactory outcomes. Natural flavones, such as apigenin (APG), have demonstrated excellent antitumoral properties. However, they have a low aqueous solubility. To overcome this drawback, APG can be encapsulated in nanostructured lipid carriers (NLC). Therefore, we developed dual NLC encapsulating APG (APG-NLC) with a lipid matrix containing rosehip oil, which is known for its anti-inflammatory and antioxidant properties.Methods: Optimisation, physicochemical characterisation, biopharmaceutical behaviour, and therapeutic efficacy of this novel nanostructured system were assessed.Results: APG-NLC were optimized obtaining an average particle size below 200 nm, a surface charge of − 20 mV, and an encapsulation efficiency over 99%. The APG-NLC released APG in a sustained manner, and the results showed that the formulation was stable for more than 10 months. In vitro studies showed that APG-NLC possess significant antiangiogenic activity in ovo and selective antiproliferative activity in several cancer cell lines without exhibiting toxicity in healthy cells.Conclusion: APG-NLC containing rosehip oil were optimised. They exhibit suitable physicochemical parameters, storage stability for more than 10 months, and prolonged APG release. Moreover, APG-NLC were internalised inside tumour cells, showing the capacity to cause cytotoxicity in cancer cells without damaging healthy cells.Keywords: antitumoral, lipid nanoparticles, apigenin, rosehip oil
first_indexed 2024-03-09T23:32:13Z
format Article
id doaj.art-7d6e0e1493264c47bc5820d406b3ceeb
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-03-09T23:32:13Z
publishDate 2023-11-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-7d6e0e1493264c47bc5820d406b3ceeb2023-11-23T17:07:56ZengDove Medical PressInternational Journal of Nanomedicine1178-20132023-11-01Volume 186979699788442Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer TreatmentBonilla-Vidal LŚwitalska MEspina MWietrzyk JGarcía MLSouto EBGliszczyńska ASánchez López ELorena Bonilla-Vidal,1,2 Marta Świtalska,3 Marta Espina,1,2 Joanna Wietrzyk,3 Maria Luisa García,1,2 Eliana B Souto,4,5 Anna Gliszczyńska,6,* Elena Sánchez López1,2,7,* 1Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, University of Barcelona, Barcelona, Spain; 2Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain; 3Department of Experimental Oncology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland; 4Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal; 5Associate Laboratory i4HB—Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; 6Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Wrocław, Poland; 7Unit of Synthesis and Biomedical Applications of Peptides, IQAC-CSIC, Barcelona, Spain*These authors contributed equally to this workCorrespondence: Elena Sánchez López; Anna Gliszczyńska, Email esanchezlopez@ub.edu; anna.gliszczynska@upwr.edu.plPurpose: Cancer is one of the major causes of death worldwide affecting more than 19 million people. Traditional cancer therapies have many adverse effects and often result in unsatisfactory outcomes. Natural flavones, such as apigenin (APG), have demonstrated excellent antitumoral properties. However, they have a low aqueous solubility. To overcome this drawback, APG can be encapsulated in nanostructured lipid carriers (NLC). Therefore, we developed dual NLC encapsulating APG (APG-NLC) with a lipid matrix containing rosehip oil, which is known for its anti-inflammatory and antioxidant properties.Methods: Optimisation, physicochemical characterisation, biopharmaceutical behaviour, and therapeutic efficacy of this novel nanostructured system were assessed.Results: APG-NLC were optimized obtaining an average particle size below 200 nm, a surface charge of − 20 mV, and an encapsulation efficiency over 99%. The APG-NLC released APG in a sustained manner, and the results showed that the formulation was stable for more than 10 months. In vitro studies showed that APG-NLC possess significant antiangiogenic activity in ovo and selective antiproliferative activity in several cancer cell lines without exhibiting toxicity in healthy cells.Conclusion: APG-NLC containing rosehip oil were optimised. They exhibit suitable physicochemical parameters, storage stability for more than 10 months, and prolonged APG release. Moreover, APG-NLC were internalised inside tumour cells, showing the capacity to cause cytotoxicity in cancer cells without damaging healthy cells.Keywords: antitumoral, lipid nanoparticles, apigenin, rosehip oilhttps://www.dovepress.com/dually-active-apigenin-loaded-nanostructured-lipid-carriers-for-cancer-peer-reviewed-fulltext-article-IJNantitumorallipid nanoparticlesapigeninrosehip oil.
spellingShingle Bonilla-Vidal L
Świtalska M
Espina M
Wietrzyk J
García ML
Souto EB
Gliszczyńska A
Sánchez López E
Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
International Journal of Nanomedicine
antitumoral
lipid nanoparticles
apigenin
rosehip oil.
title Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
title_full Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
title_fullStr Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
title_full_unstemmed Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
title_short Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
title_sort dually active apigenin loaded nanostructured lipid carriers for cancer treatment
topic antitumoral
lipid nanoparticles
apigenin
rosehip oil.
url https://www.dovepress.com/dually-active-apigenin-loaded-nanostructured-lipid-carriers-for-cancer-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT bonillavidall duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment
AT switalskam duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment
AT espinam duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment
AT wietrzykj duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment
AT garciaml duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment
AT soutoeb duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment
AT gliszczynskaa duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment
AT sanchezlopeze duallyactiveapigeninloadednanostructuredlipidcarriersforcancertreatment